Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Virus product could kill anthrax and beat antibiotic resistance

07.09.2004


Researchers from Rockefeller University, New York, have developed a new way of killing dangerous bacteria like the ones which cause anthrax and pneumonia, using products from a virus, according to new research presented today (Tuesday, 07 September 2004) at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.



The new bug-smashing technique uses the bacteria’s own natural enemies, tiny viruses called bacteriophages (or phages), which can infect bacterial cells. The phages make thousands of copies of themselves inside infected bacteria, but then need to dissolve the bacteria’s cell wall to get out and infect other bacterial cells.

“We realised that bacteria have no effective natural defences against these phages once they have been infected,” says Professor Vincent Fischetti of Rockefeller University. “After infection, the phages make an enzyme to dissolve the bacterial cell walls for release and we found that we could use the same enzyme to attack and kill the disease bacteria responsible for pneumonia, anthrax or strep throat.”


The enzymes work on contact, killing the disease bacteria instantly, but without harming other friendly types of bacteria. This offers huge advantages over conventional antibiotics, which indiscriminately kill most bacteria, including our useful ones, and which can lead to disease resistance building up if used too frequently.

“About half of us normally carry disease bacteria in our nose or throat, but without symptoms, which form the only reservoir for these organisms in the environment, allowing them to travel from person to person until they are able to cause infection in the right individual,” says Prof Fischetti. “Removing these bacteria from people in hospitals, day care centres and nursing homes could have a major impact on disease outbreaks amongst vulnerable people in these settings.”

The novel technique offers medical workers an opportunity to control disease bacteria in a completely new way. So far no resistance has been found to the enzymes, but if it were to occur it would be very rare, much rarer than antibiotic resistance. The enzymes successfully kill antibiotic-resistant bacteria that are causing a major problem in hospitals and nursing homes.

“We now have enzymes that kill all bacteria of a particular type, called Gram-positive bacteria, of the major disease-causing organisms, including bacteria for strep throat, pneumonia, neonatal meningitis, endocarditis and anthrax,” says Prof Fischetti. “Since we have never found any resistance to the enzymes, they can be used safely, long term, even to kill recurrent infections.”

In addition, the scientists are currently carrying out clinical trials of an enzyme which can specifically kill anthrax in the blood. This could be used during a terrorist attack or emergency to save the lives of exposed individuals.

Faye Jones | alfa
Further information:
http://www.sgm.ac.uk

More articles from Life Sciences:

nachricht Rochester scientists discover gene controlling genetic recombination rates
23.04.2018 | University of Rochester

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Structured light and nanomaterials open new ways to tailor light at the nanoscale

23.04.2018 | Physics and Astronomy

On the shape of the 'petal' for the dissipation curve

23.04.2018 | Physics and Astronomy

Clean and Efficient – Fraunhofer ISE Presents Hydrogen Technologies at the HANNOVER MESSE 2018

23.04.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>